Tesamorelin: The Only FDA-Approved GHRH Analog for HIV-Associated Lipodystrophy
Tesamorelin: The Only FDA-Approved GHRH Analog for HIV-Associated Lipodystrophy
Key Takeaways
- Tesamorelin is the only FDA-approved synthetic growth hormone-releasing hormone (GHRH) analog, specifically indicated for HIV-associated lipodystrophy
- Clinical trials show 15-18% reduction in visceral adipose tissue over 26 weeks at the standard 2mg daily